Sio Capital Management, LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 135 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sio Capital Management, LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,586,672
-23.0%
595,002
+12.8%
2.04%
-6.3%
Q2 2023$8,553,320
+105.5%
527,657
+111.1%
2.18%
+5.7%
Q1 2023$4,162,500
+44.0%
250,000
-75.0%
2.06%
+89.7%
Q2 2022$2,890,000
-3.6%
999,8290.0%1.08%
+9.4%
Q1 2022$2,999,000
-1.3%
999,829
+51.3%
0.99%
+8.3%
Q4 2021$3,040,000
-26.7%
660,8130.0%0.92%
-30.8%
Q3 2021$4,150,000
+11.8%
660,813
+6.6%
1.32%
+43.3%
Q2 2021$3,712,000
+3.0%
619,780
+8.8%
0.92%
+26.1%
Q1 2021$3,604,000
+5.0%
569,780
-6.6%
0.73%
+4.1%
Q4 2020$3,433,000
-16.9%
609,780
-14.1%
0.70%
-14.1%
Q3 2020$4,131,000
-19.3%
709,7800.0%0.82%
-45.2%
Q2 2020$5,118,000
+45.4%
709,780
-5.6%
1.49%
+26.6%
Q1 2020$3,520,000
-40.0%
752,241
+2.8%
1.18%
-15.5%
Q4 2019$5,866,000
+13.0%
731,453
-3.1%
1.40%
-16.5%
Q3 2019$5,193,000
-17.1%
754,7590.0%1.67%
+10.8%
Q2 2019$6,264,000
-26.0%
754,759
-11.4%
1.51%
-34.0%
Q1 2019$8,470,000
+73.8%
852,160
+33.8%
2.29%
+28.8%
Q4 2018$4,873,000
+31.2%
637,046
+198.7%
1.78%
+39.2%
Q3 2018$3,715,000
+39.1%
213,252
-24.2%
1.28%
-13.6%
Q2 2018$2,670,000
-52.2%
281,304
-78.0%
1.48%
-56.0%
Q1 2018$5,580,000
+9.9%
1,276,845
+2.1%
3.35%
+17.1%
Q4 2017$5,076,000
+326.2%
1,250,250
+47.1%
2.86%
+248.7%
Q3 2016$1,191,000
+70.4%
849,905
+53.3%
0.82%
+130.0%
Q2 2016$699,000554,3820.36%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders